1 Min Read
Jan 3 (Reuters) - Nuevolution Ab (Publ):
* GETS LICENCE FEE OF USD 750,000 FROM JANSSEN BIOTECH TO USE THE RESEARCH PROGRAMME Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.